These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5357133)

  • 21. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rifampicin in the treatment of tuberculosis in patients with diabetes mellitus].
    Markova EF; Gortsunian DK
    Probl Tuberk; 1987; (6):39-41. PubMed ID: 3628210
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of Soviet-made rifampicin in pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Kolesnikova ZhIa; Petrash OV
    Vrach Delo; 1978 Oct; (10):52-6. PubMed ID: 716359
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anatomo-bacteriological criteria of the effect of rifampicin in the treatment of pulmonary tuberculosis].
    Morère P; Stain JP; Hubert J; Chauvet MC
    Rev Tuberc Pneumol (Paris); 1970; 34(5):714. PubMed ID: 5496794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Note on a clinical trial of rifampicin in the treatment of pulmonary tuberculosis].
    Robustelli Pisani F
    G Ital Mal Torace; 1969; ():Suppl 2:85+. PubMed ID: 4982436
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rifampicin in the treatment of pulmonary tuberculosis].
    Bumbăcescu N; Ionescu C
    Ftiziologia; 1971; 20(6):619-22. PubMed ID: 5162288
    [No Abstract]   [Full Text] [Related]  

  • 27. [Direct genetic analysis of the rifampicin resistance of M. tuberculosis isolates in sputum samples].
    Generozov EV; Akopian TA; Vladimirskiĭ MA; Shipina LK; Irtuganova OA; Govorun VM
    Probl Tuberk Bolezn Legk; 2003; (4):49-52. PubMed ID: 12774423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trial of rifampicin as sole therapy. Study of serum levels].
    Brouet G; Modaï J; Vergez P
    Rev Tuberc Pneumol (Paris); 1969; 33(1):27-42. PubMed ID: 5360580
    [No Abstract]   [Full Text] [Related]  

  • 30. [Corticosteroids in the treatment of cavitating pulmonary tuberculosis (author's transl)].
    Saatçi H; Meral N
    Prax Klin Pneumol; 1980 Jan; 34(1):42-4. PubMed ID: 7367380
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary results of treatment of pulmonary tuberculosis with rifampicin].
    Pozzi G; Ferraro S
    G Ital Mal Torace; 1969; ():Suppl 2:17-31. PubMed ID: 5357135
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bacteriologic and radiologic development of 70 pulmonary tuberculosis patients treated with rifampicin].
    Weill G; Varin E; Lévy A; Stoeckel C
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):279-82. PubMed ID: 4989070
    [No Abstract]   [Full Text] [Related]  

  • 34. [The clinical use of rifampicin in tuberculosis].
    Giuliano V
    G Ital Mal Torace; 1969; ():Suppl 2:50-9. PubMed ID: 5357139
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis].
    Chernushenko EF; Kogosova LS; Il'nitskiĭ IG; Petrashenko AI; Goncharova SI
    Probl Tuberk; 1989; (7):39-43. PubMed ID: 2798385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pulmonary tuberculosis with diabetes mellitus--with special reference to the result of sputum examination and drug resistance].
    Shibata M
    Iryo; 1967 Mar; 21(3):355-60. PubMed ID: 6061981
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.
    Engbaek HC; Vergmann B
    Scand J Respir Dis; 1970; 51(1):11-27. PubMed ID: 5456856
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of rifampicin (R-AMP) in chronic pulmonary tuberculosis].
    Casalone G; Giura R; Lusco G
    G Ital Mal Torace; 1968; 22(4):215-8. PubMed ID: 5743003
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of a Soviet preparation of rifampicin for intravenous injection in the treatment of patients with destructive tuberculosis of the lungs].
    Ivaniuta OM; Panasiuk AV; Il'nitskiĭ IG; Davyda RS; Kunichkina SA
    Vrach Delo; 1985 Nov; (11):32-4. PubMed ID: 4082545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.